Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis

Journal of Immunology

Volumn 163, Issue 8, 1999, Pages 4224-4231

  Johnsen, A K ^a   Templeton, D J ^a   Sy, M S ^a   Harding, C V ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL SELECTION; CELL SURVIVAL; CELL TRANSFORMATION; CELLULAR IMMUNITY; FEMALE; IMMUNOSURVEILLANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FIBROBLASTS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; RNA, MESSENGER; SARCOMA, EXPERIMENTAL; T-LYMPHOCYTES; TRANSFECTION;

EID: 0032876395     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725.
2. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. Van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12: 337.
3. van den Eynde, B. J., and P. van der Bruggen. 1997. T cell defined tumor antigens. Curr. Opin. Immunol. 9:684.
4. Sogn, J. A. 1998. Tumor immunology: the glass is half full. Immunity 9:757.
5. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Scbneider, T. Bornand, A. Fontana, D. Lienard, et al. 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363.
6. O'Connell, J., M. W. Bennett, G. C. O'Sullivan, J. K. Collins, and F. Shanahan. 1999. The Fas counterattack: cancer as a site of immune privilege. Immunol. Today 20:46.
7. Allison, J. P., A. A. Hurwitz, and D. R. Leach. 1995. Manipulation of costimulatory signals to enhance antitumor T-cell responses. Curr. Opin. Immunol. 7:682.
8. Chen, L. 1998. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol. Today 19:27.
9. Garrido, F., T. Cabrera, A. Concha, S. Glew, F. Ruiz-Cabello, and P. L. Stern. 1993. Natural history of HLA expression during tumour development. Immunol. Today 14:491.
10. Ferrone, S., and F. M. Marincola. 1995. Loss of HLA class 1 antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today 16:487.
11. Johnsen, A., J. France, M. S. Sy, and C. V. Harding. 1998. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res. 58:3660.
12. Restifo, N. P., F. Esquivel, Y. Kawakami, J. W. Yewdell, J. J. Mule, S. A. Rosenberg, and J. R. Bennink. 1993. Identification of human cancers deficient in antigen processing. J. Exp. Med. 177:265.
13. Cromme, F. V., P. F. Van Bommel, J. M. Walboomers, M. P. Gallee, P. L. Stern, P. Kenemans, T. J. Helmerhorst, M. J. Stukart, and C. J. Meijer. 1994. Differences in MHC and TAP-1 expression in cervical cancer lymph node melastases as compared with the primary tumours. Br. J. Cancer 69:1176.
14. Cromme, F. V., J. Airey, M. T. Heemels, H. L. Pleogh, P. J. Keating, P. L. Stern, C. J. Meijer, and J. M. Walboomers. 1994. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med. 179:335.
15. Kaklamanis, L., A. Townsend, I. A. Doussis-Anagnostopoulou, N. Mortensen, A. L. Harris, and K. C. Garter. 1994. Loss of major histocompatibility complex-encoded transporter asociated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol. 145:505.
16. Kaklamanis, L., R. Leek, M. Koukourakis, K. C. Gatter, and A. L. Harris. 1995. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metaslatic versus primary breast cancer. Cancer Res. 55:5191.
17. Sanda, M. G., N. P. Restifo, J. C. Walsh, Y. Kawakami, W. G. Nelson, D. M. Pardoll, and J. W. Simons. 1995. Molecular characterization of defective antigen processing in human prostate cancer. J. Natl Cancer Inst. 87:280.
18. Seliger, B., A. Höhne, A. Knuth, H. Bernhard, T. Meyer, R. Tampe, F. Momburg, and C. Huber. 1996. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res. 56: 1756.
19. Korkolopoulou, P., L. Kaklamanis, F. Pezzella, A. L. Harris, and K. C. Gatter. 1996. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br. J. Cancer 73:148.
20. Kearing, P. J., F. V. Cromme, M. Duggan-Keen, P. J. Snijders, J. M. Walboomers, R. D. Hunter, P. A. Dyer, and P. L. Stem. 1995. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br. J. Cancer 72:405.
21. Kurokohchi, K., M. Carrington, D. L. Mann, T. B. Simonis, M. A. Alexander-Miller, S. M. Feinslone, T. Akatsuka, and J. A. Berzofsky. 1996. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology 23:1181.
22. Alpan, R. S., M. Zhang, and A. B. Pardee. 1996. Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line. Cancer Res. 56:4358.
23. Maeurer, M. J., S. M. Gollin, D. Martin, W. Swaney, J. Bryant, C. Castelli, P. Robbins, G. Parmiani, W. J. Storkus, and M. T. Lotze. 1996. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J. Clin. Invest. 98:1633.
24. Chen, H. L., D. Gabrilovich, R. Tampe, K. R. Girgis, S. Nadaf, and D. P. Carbone. 1996. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nat. Genet. 13:210.
25. Vitale, M., R. Rezzani, L. Rodella, G. Zauli, P. Grigolato, M. Cadei, D. J. Hicklin, and S. Ferrone. 1998. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 58:737.
26. Seliger, B., A. Höhne, A. Knuth, H. Bernhard, B. Ehring, R. Tampe, and C. Huber. 1996. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin. Cancer Res. 2:1427.
27. Seliger, B., M. J. Maeurer, and S. Ferrone. 1997. TAP off-tumors on. Immunol. Today 18:292.
28. Singal, D. P., M. Ye, J. Ni, and D. P. Snider. 1996. Markedly decreased expression of TAP 1 and LMP2 genes in HLA class I-deficient human tumor cell lines. Immunol. Lett. 50:149.
29. Maeurer, M. J., S. M. Gollin, W. J. Storkus, W. Swaney, J. Karbach, D. Martin, C. Castelli, R. Salter, A. Knuth. and M. T. Lotze. 1996. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6. Clin. Cancer Res. 2:641.
30. Rowe, M., R. Khanna, C. A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S. R. Burrows, et al. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur. J. Immunol. 25:1374.
31. + proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr. Biol. 5:923.
32. Franksson, L., E. George, S. Powis, G. Butcher, J. Howard, and K. Karre. 1993. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J. Exp. Med. 177:201.
33. + T cells. Cell 71:1205.
34. Brown, M., J. Figge, U. Hansen, C. Wright, K. T. Jeang, G. Khoury, D. M. Livingston. and T. M. Roberts. 1987. lac represser can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49:603.
35. Dotto, G. P., L. F. Parada, and R. A. Weinberg. 1985. Specific growth response of ras-transformed embryo fibroblasts to tumour promoters. Nature 318:472.
36. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587.
37. Struhl, K. 1987. Subcloning of DNA fragments. In Current Protocols in Molecular Biology, Vol. 1. F. M. Ausubel, R. Brent, R. E. Kingston. D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, New York, p. 3.16.1.
38. Kingston, R. E., C. A. Chen, H. Okayama, and J. K. Rose. 1996. Transfection of DNA into eukaryotic cells. In Current Protocols in Molecular Biology, Vol. 1. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. John Wiley & Sons, New York, p. 9.1.1.
39. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533.
40. Huang, A. Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264:961.
41. Falo, L. D., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. 1:649.
42. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
43. Carbone, F. R., C. Kurts, S. R. Bennett, J. F. Miller, and W, R. Heath. 1998. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today 19:368.
44. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
45. Harding, C. V. 1995. Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol. 5:105.
46. Kovacsovics-Bankowski, M., and K. L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243.
47. Huang, A. Y. C., A. T. Brace, D. M. Pardoll, and H. I. Levitsky. 1996. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4:349.
48. Schirmbeck, R., K. Melber, and J. Reimann. 1995. Hepatitis B virus small surface antigen panicles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1063.
49. Pfeifer, J. D., M. J. Wick, R. L. Roberts, K. F. Findlay, S. J. Normark, and C. V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359.
50. 2-microglobulin in the processing of bacterial or paniculate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:4182.
51. Song, R., A. Porgador, and C. V. Harding. 1999. Peptide-receptive class I MHC molecules on TAP-deficient and wild type cells and their roles in the processing of exogenous antigens. Immunology. 97:316.
52. Day, P. M., F. Esquivel, J. Lukszo, J. R. Bennink, and J. W. Yewdell. 1995. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity 2:137.